<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03584126</url>
  </required_header>
  <id_info>
    <org_study_id>20117/04.10.2016</org_study_id>
    <nct_id>NCT03584126</nct_id>
  </id_info>
  <brief_title>Imaging-based, Non-invasive Diagnosis of Persistent Atrial Fibrillation</brief_title>
  <acronym>imATFIB</acronym>
  <official_title>Imaging-based, Non-invasive Diagnosis of Persistent Atrial Fibrillation - imATFIB</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>County Clinical Emergency Hospital Cluj-Napoca</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>County Clinical Emergency Hospital Cluj-Napoca</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The main objective of the present project is to develop an imaging-based tool to determine&#xD;
      the origin and cause of persistent atrial fibrillation (AF). The result of the study is a&#xD;
      diagnostic method which aids the medical work-up of patients suffering from this disease.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Atrial fibrillation (AF) is the most common arrhythmia associated with substantial morbidity&#xD;
      and mortality in humans. Histopathological studies of persistent AF have reported&#xD;
      extracellular matrix remodeling with fibrotic infiltration which may cause atrial dilation.&#xD;
      The degree of the fibrosis might have a significant impact on wave propagation during AF. The&#xD;
      main objective of the present project is to develop an imaging-based tool to determine the&#xD;
      origin and cause of persistent AF. The obtained clinical parameters of patients and controls&#xD;
      (electrocardiography, ecocardiography and MR imaging data) will be correlated with known&#xD;
      markers in order to identify novel markers for AF diagnosis.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 25, 2017</start_date>
  <completion_date type="Actual">August 31, 2020</completion_date>
  <primary_completion_date type="Actual">August 31, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Other</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Correlation of the presence, localization and quantity of left atrial fibrosis assessed by MRI in patients with persistent atrial fibrillation.</measure>
    <time_frame>2016-2020</time_frame>
    <description>A. Percentage of patients with left atrial fibrosis assessed by MRI among those with persistent atrial fibrillation.&#xD;
B. Correlation of the left atrial fibrosis localization and amount with persistent atrial fibrillation severity.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Specificity of left atrial fibrosis for persistent atrial fibrillation by comparing fibrosis in patients and healthy volunteers.</measure>
    <time_frame>2016-2020</time_frame>
    <description>A. Correlation of left atrial fibrosis with left atrial dimensions in patients and healthy volunteers.&#xD;
B. Correlation of left atrial fibrosis with blood bio-marker levels and echocardiography parameters in patients and healthy volunteers.</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">123</enrollment>
  <condition>Atrial Fibrillation</condition>
  <arm_group>
    <arm_group_label>Patients with AF</arm_group_label>
    <description>Patients with atrial fibrillation visiting the outpatient clinic; examined by general examination, electrocardiography, ecocardiography and MRI.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <description>Healthy adult volunteers; examined by the study physicians by general examination, electrocardiography, ecocardiography and MRI.</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Electrocardiography, ecocardiography and MRI.</intervention_name>
    <description>AF patients and healthy adult volunteers will be examined by the study physicians and included in the study according to the inclusion criteria. After a general examination, an electrocardiography, an ecocardiography and an MRI will be performed on the AF-affected and healthy hearts, respectively.</description>
    <arm_group_label>Control</arm_group_label>
    <arm_group_label>Patients with AF</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Blood&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Adult population presented at the cardiologist with persistent, permanent or paroxysmal&#xD;
        atrial fibrillation (AF).&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  age: 20-80 years&#xD;
&#xD;
          -  weight: 50-120 kg&#xD;
&#xD;
          -  persistent, permanent or paroxysmal atrial fibrillation&#xD;
&#xD;
          -  clinically stable patients: outside of an acute cardiac event with constant chronic&#xD;
             medication&#xD;
&#xD;
          -  optimum echographic window&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  patients with: rheumatic mitral disease; acute myocardial-pericarditis; chronic&#xD;
             rheumatism, under chronic or immunomodulatory treatment; infectious-inflammatory&#xD;
             process of any cause&#xD;
&#xD;
          -  patients undergoing oncology treatment&#xD;
&#xD;
          -  patients under medication in another study&#xD;
&#xD;
          -  patients undergoing immunosuppressive therapy&#xD;
&#xD;
          -  contraindication for magnetic resonance imaging (MRI)&#xD;
&#xD;
          -  patients with valvular prosthesis, pacemaker of any type, metallic elements in the&#xD;
             body (including metal particles accidentally in the body or as a result of exercising&#xD;
             certain professions); pregnant patients; patients with known poly-allergy; patients&#xD;
             with altered renal function (creatinine clearance &lt;40 mL/min determined by the&#xD;
             Cockcroft-Gault formula).&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Zoltán Bálint, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>County Clinical Emergency Hospital Cluj-Napoca</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>County Clinical Emergency Hospital of Cluj-Napoca</name>
      <address>
        <city>Cluj-Napoca</city>
        <state>Cluj</state>
        <zip>400006</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Romania</country>
  </location_countries>
  <verification_date>September 2020</verification_date>
  <study_first_submitted>June 19, 2018</study_first_submitted>
  <study_first_submitted_qc>July 10, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">July 12, 2018</study_first_posted>
  <last_update_submitted>September 10, 2020</last_update_submitted>
  <last_update_submitted_qc>September 10, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">September 11, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atrial Fibrillation</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

